Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001140361-20-002903
Filing Date
2020-02-12
Accepted
2020-02-12 15:19:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 13G formsc13g.htm SC 13G 67662
  Complete submission text file 0001140361-20-002903.txt   69142
Mailing Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158
Business Address 605 THIRD AVENUE 38TH FLOOR NEW YORK NY 10158 212-610-6100
Nikko Asset Management Americas, Inc. (Filed by) CIK: 0001480751 (see all company filings)

EIN.: 941302123 | State of Incorp.: DE | Fiscal Year End: 0310
Type: SC 13G

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Subject) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89674 | Film No.: 20603704
SIC: 2836 Biological Products, (No Diagnostic Substances)